Journals / Tüberküloz ve Toraks / 2008 / Cilt: 56 - Sayı: 2

Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin

Ratlarda bleomisin ile oluşturulan akciğer fibrozisinde erdosteinin inflamasyon ve fibrozis üzerine etkileri

Pages
127–138
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When BLM group compared to erdostein group, the levels of MDA, MIP-1α, MIP-2, and neutrophil counts, the hydroxyproline (OH-P) level of lung tisssue were decreased in erdostein group on acute inflammatory phase (day 14) (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We aimed to investigate the levels of some chemokines, inflammatory cell counts in bronchoalveolar lavage fluid (BALF), histopathological changes in lung tissue, to determine the effect of erdosteine on acute inflammatory changes and fibrosis in a rat fibrosis model induced by Bleomycine (BLM).
📊
Key Findings & Data:On day 0, intra tracheal (i.t.) saline to control group (group 1, n=15), i.t bleomycine 7.5 U/kg to bleomycine (group 2, n=15) and erdostein group (group 3, n=15) was administered.
💡
Conclusion & Impact:When BLM group compared to erdostein group, the levels of MDA, MIP-1α, MIP-2, and neutrophil counts, the hydroxyproline (OH-P) level of lung tisssue were decreased in erdostein group on acute inflammatory phase (day 14) (p
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We aimed to investigate the levels of some chemokines, inflammatory cell counts in bronchoalveolar lavage fluid (BALF), histopathological changes in lung tissue, to determine the effect of erdosteine on acute inflammatory changes and fibrosis in a rat fibrosis model induced by Bleomycine (BLM). Forty-five Wistar male rats were taken into the study. On day 0, intra tracheal (i.t.) saline to control group (group 1, n=15), i.t bleomycine 7.5 U/kg to bleomycine (group 2, n=15) and erdostein group (group 3, n=15) was administered. In group 3, oral erdostein (10 mg/kg/day) was applied two days before bleomycine. On day 0, 14, and 29. five rats in each groups were sacrificed, BALF was performed. Malonyldialdehyde (MDA), macrophage inflammatory protein 1 alpha (MIP-1α), MIP-2 levels in BALF, hydroxyproline levels in lung tissue were measured. Histopathological examination was performed. When BLM group compared to erdostein group, the levels of MDA, MIP-1α, MIP-2, and neutrophil counts, the hydroxyproline (OH-P) level of lung tisssue were decreased in erdostein group on acute inflammatory phase (day 14) (p

Özet

Bleomisin (BLM) uygulaması ile ratlarda akciğer fibrozisi oluşturarak, akut inflamatuvar ve fibrotik fazlarda akciğer dokusunda ve bronkoalveolar lavaj (BAL) sıvısında bazı kemokin ve sitokinlerin düzeyini, akciğer dokusunda oluşan histopatolojik değişiklikleri ve antioksidan etkisi olan erdosteinin akut inflamatuvar değişiklikler ve fibrozis üzerine etkilerini araştırmayı amaçladık. Çalışmaya Wistar tipi 45 erkek rat alındı. 0.günde; kontrol grubuna (grup 1, n=15) intratrakeal (i.t.) salin, BLM (grup 2, n=15) ve erdostein grubuna (grup 3, n=15) i.t. BLM (7.5 U/kg) uygulandı. Erdostein grubuna BLM uygulamasında 2 gün önce peroral 10 mg/kg/gün erdostein başlandı. Tüm gruplarda 0., 14. ve 29. günde 5’er adet rat sakrifiye edilerek BAL yapıldı. BAL’da malondialdehit (MDA), makrofaj inflamatuar protein 1 alfa (MIP-1α), MIP-2 düzeylerinin ölçümü ve inflamatuvar hücre sayımı, akciğer dokusunda hidroksiprolin ölçümü ve histopatolojik inceleme yapıldı. BLM grubu ile karşılaştırıldığında erdostein grubunun BAL sıvısında nötrofil, MIP-1α, MIP-2, MDA düzeylerinin ve akciğer dokusunda hidroksiprolin (OH-P) içeriğinin akut inflamatuvar fazda (14. gün) (sırasıyla, p

🔖

Cite This Article

İLHAN, N., ÇOBANOĞLU, B., TURGUT, T., MUZ, M. H., KIRGIL, G., DEVECİ, F., ERDEN, E. Ş. (2022). Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin. Tüberküloz ve Toraks, Cilt: 56 - Sayı: 2, 127–138. https://ajindex.com/articles/619009

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Goldstein RH, Fine A. Potential therapeutic initiatives for fibrogenic lung disease. Chest 1995; 108: 848-55
  2. Sausville EA, Stein RW, Peisach J, Horwitz SB. Properties and products of degradation of DNA by bleomycin and iron (II). Biochemistry 1978; 17: 2746-54
  3. Galvan L, Huang CH, Prestayko AW, et al. Inhibition of bleomycine-induced DNA breakage by superoxide dismutase. Cancer Res 1981; 41: 5103-6
  4. Cunningham ML, Ringrose PS, Lokesh BR. Inhibition of the genotoxicity of bleomicin by superoxide dismutase. Mutat Res 1984; 135: 199-202
  5. Hagiwara S, Ishii Y, Kitamura S. Aerolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomicin in mice. Am J Respir Crit Care Med 2000;162: 225-31
  6. Crystal RG, Bitterman PB, Rennard SI, et al. Interstitial lung diseases unknown cause: Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984; 310: 154-66
  7. Olivieri D, Del-Donno M, Casalini A, et al. Activity of erdosteine on mucociliary transport in patients affected by chronic bronchitis. Respiration 1991; 58: 91-4
  8. Biagi GL, Fregnan GB, Gazzani G, Vandoni G. Erdosteine protection from cigarette smoke-induced loss of α1-antitrypsin activity in rat lungs. Int J Clin Pharmacol Ther Toxicol 1989; 27: 235-7
  9. Inglesi M, Nicola M, Fregnan GB, et al. Synthesis and free radical scavening properties of the enantiomers of erdosteine. Farmaco 1994; 40: 703-8
  10. Vagliasindi M, Fregnan GB. Erdosteine protection against cigarette smoking-induced functional antiprotease deficiency in human bronchiolo-alveolar structures. Int J Clin Pharmacol Ther Toxicol 1989; 27: 238-41
  11. Ozyurt H, Söğüt S, Yildirim Z, et al. Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clin Chim Acta 2004; 339: 65-75
  12. Boyaci H, Maral H, Turan G, et al. Effects of erdosteine on bleomycin-induced lung fibrosis in rats. Mol Cell Biochem 2006; 281: 129-37
  13. Wang HD, Yamaya M, Okinaga S, et al. Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med 2002; 165: 406-11
  14. Wang YH, Bai CX, Hong QY, Chen J. Anti-inflammatory effect of methoxyphenamine compound in rat model of chronic obstructive pulmonary disease. Acta Pharmacol Sin 2003; 24: 1324-7
  15. Agarwal R, Chase SD. Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 775: 121-6.